Industry research
Scope
Europe
Companies
68
Table of contents
The European digital health market was valued at ~€38.8bn in 2025 and is projected to grow at a ~7.7% CAGR between 2025 and 2029, reaching ~€52.2bn by the end of the period (Statista, September 2024)
According to Statista (September 2024), the European online doctor consultation market was estimated to increase from ~€2.5bn in 2025 to ~€2.9bn in 2029 (~3.7% CAGR)
EU governments support telemedicine adoption via relaxed regulations to tackle healthcare workforce shortages and improve overall efficiency (OECD, November 2024; The Health Foundation, January 2025). For example, Norway accepts sick leave filings via online consultations, while the NHS implemented “virtual wards” to speed up patient discharge processes and treat patients at home (WHO, October 2024; Tech Monitor, March 2023)
An ageing population and a rise in chronic diseases drive the demand for efficient patient monitoring. Telemedicine and mobile health platforms are well positioned to alleviate this growing issue, offering more efficient and cost-effective ways to support patient care (McKinsey & Company, January 2023; OECD, November 2024)
Technological advancements, such as 5G deployment, AI and advanced IoT systems, can improve the reach to patients in more remote areas and the monitoring of their health and treatment, expanding the addressable markets for telemedicine players (Intelligent Pharmacy, January 2025)
With the increasing number of data breaches in the medical sector, preventive regulatory requirements become increasingly stringent (e.g. GDPR; Medium, February 2024). As a result, telemedicine incumbents are obliged to invest heavily in cybersecurity and regulatory compliance without any clear upside, thereby affecting margins in the long run (interview by Gain.pro)
True scalability of telemedicine has yet to be proven, as national healthcare reimbursement schemes lag behind in-person medical consultations, notably due to doctors’ liability and clinical risks. The expansion is further inhibited by the lack of cross-border interoperability of regulatory frameworks and healthcare systems across Europe (European Papers, March 2024)
Limited allocation of public healthcare funds to telemedicine and mobile health players. In 2024, only ~26% of member states allocated these funds to telemedicine, posing challenges for growth and development for incumbents (World Health Organization, October 2024; European Court of Auditors, October 2024)
With the full report, you’ll gain access to:
Detailed assessments of the market outlook
Insights from c-suite industry executives
A clear overview of all active investors in the industry
An in-depth look into 68 private companies, incl. financials, ownership details and more.
A view on all 345 deals in the industry
ESG assessments with highlighted ESG outperformers
